Supernus Pharmaceuticals | SUPN - Ordinary Share Capital


Supernus Pharmaceuticals reported $57.12M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
ANI Pharmaceuticals USD 21.73M 21.73M Jun/2025
Aurora Cannabis CAD 6.98B 907K Dec/2024
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 332.38M 127.23M Sep/2025
Cara Therapeutics USD 2K 3K Mar/2025
Corcept Therapeutics USD 105.12M 164K Sep/2025
Eisai JPY 282.11M 1000 Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Novo Nordisk DKK 4.44B 0 Dec/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 0 Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025